Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag in severe and very severe aplastic anemia
NCT01703169Phase 2Completed
- Sponsor
- University of Utah
- Start
- Nov 2012
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltrombopag in aplastic anemia, sponsored by University of Utah. Started Nov 2012; status: completed.
02
Drugs
eltrombopag
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT01703169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01703169.